Bristol Myers wins latest test for Krazati (NYSE:BMY)
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its FDA-cleared cancer therapy Krazati (adagrasib), ...
Tag: Bristol
Schrodinger recovers rights to cancer drug candidate from Bristol
koto_feja Bristol-Myers Squibb (New York Stock Exchange:BMY) has returned the rights to a preclinical cancer drug candidate, an SOS1 inhibitor, ...
Bristol Myers therapy for schizophrenia safe in late-stage trial
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its experimental schizophrenia therapy KarXT, acquired ...
RayzeBio Soars; Bristol Myers to pay $4.1 billion in second major purchase in three days
RayzeBio shares nearly doubled in early trading Tuesday after the cancer drug specialists agreed to a $4.1 billion acquisition by ...
Stocks Fall, Oil Rises, Bristol Myers-Mirati Deal, UAW Mack Truck Strikes, Peltz Eyes Seat at Disney: 5 Things to Know
Five things you need to know before the market opens on Monday, October 9:1. -- stock market Today: stocks Fall, ...
UK DeepTech gets another boost with new $100M SCVC fund out of Bristol
Europe has far too few VCs created by former founders, or “Operators” as the industry often likes to call them. ...
Recommended.
